This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
midgardfinance.com
midgardfinance.com
did:plc:6elkozr74dmgtebnjmwcre7e
🇩🇰 $NOVO ran CagriSema head to head against 🇺🇸 $LLY Tirzepatide, and reported it in one line.
#REIMAGINE4, 68 weeks: weight loss 15.2% vs 15.8%, HbA1c 1.9 vs 2.2 points. Non-inferiority met on weight, not met on glucose.
midgardfinance.com/companies/NOVO-B.CO/
#pharma $NVO #CagriSema #Tirzepatide
2026-08-06T14:35:25.074Z